Live Breaking News & Updates on Cosmetic Business Unit

Stay updated with breaking news from Cosmetic business unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A approved the Group's Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13.5%, exceeding historical levels

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A approved the Group's Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13.5%, exceeding historical levels
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Verdellino Bergamo , Giorgio Ferraris , Pharmaceuticals Business Unit , Fine Foods Pharmaceuticals , Group Net Financial Position , Board Of Directors Fine Foods Pharmaceuticals , International Accounting Standards Board , Contract Development Manufacturing Organisation , Group Interim Financial , Fine Foods , Interim Financial Report , Net Financial Position , Contract Development , Manufacturing Organisation , Consolidated Revenue , Business Unit , Cosmetic Business Unit ,